Virtu Financial LLC Geron Corp Transaction History

Virtu Financial LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$1.97 - $3.69 $169,037 - $316,624	85,806 New	85,806 $275,000
Q3 2022 Nov 07, 2022	BUY	$1.67 - $2.94 $96,724 - $170,281	57,919 New	57,919 $136,000
Q2 2022 Aug 09, 2022	SELL	$1.19 - $1.65 $178,219 - $247,110	-149,764 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.99 - $1.6 $148,266 - $239,622	149,764 New	149,764 $204,000
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $824,847 - $1.03 Million	-687,373 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$1.25 - $1.83 $859,216 - $1.26 Million	687,373 New	687,373 $969,000
Q4 2020 Feb 24, 2021	SELL	$1.55 - $2.05 $56,216 - $74,351	-36,269 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$1.59 - $2.19 $57,667 - $79,429	36,269 New	36,269 $63,000
Q2 2020 Aug 07, 2020	SELL	$1.05 - $2.18 $60,113 - $124,807	-57,251 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.27 - $1.54 $72,708 - $88,166	57,251 New	57,251 $78,000
Q3 2019 Nov 20, 2019	SELL	$1.15 - $1.59 $61,593 - $85,160	-53,560 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.37 - $2.02 $17,681 - $26,070	12,906 Added 31.75%	53,560 $75,000
Q1 2019 Apr 12, 2019	SELL	$1.01 - $1.83 $149,112 - $270,173	-147,636 Reduced 78.41%	40,654 $67,000
Q4 2018 Jan 16, 2019	BUY	$0.98 - $1.85 $69,736 - $131,646	71,160 Added 60.75%	188,290 $188,000
Q1 2018 May 14, 2018	BUY	$1.81 - $5.98 $184,390 - $609,200	101,873 Added 667.71%	117,130 $498,000
Q4 2017 Feb 09, 2018	SELL	$1.8 - $2.32 $161,254 - $207,839	-89,586 Reduced 85.45%	15,257 $27,000
Q3 2017 Nov 15, 2017	BUY	$1.99 - $2.65 $208,637 - $277,833	104,843	104,843 $0

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.